Technology | June 22, 2012

Philips Introduces iDose4 Premium Package

June 22, 2012 — Philips introduced the iDose4 Premium Package, which includes two technologies that can improve image quality: the iDose4 iterative reconstruction technique, and metal artifact reduction for large orthopedic implants (O-MAR).

iDose4 allows radiologists to personalize image quality based on each patient’s needs. This advanced iterative reconstruction technique provides up to 57 percent improvement in spatial resolution at low dose, and the majority of iDose4 reference protocols are reconstructed in 60 seconds or less. Image quality is enhanced through (O-MAR), which reduces artifacts caused by large metal implants, such as prosthetic hip replacements. Together, the technologies of the iDose4 Premium Package (iDose4 and O-MAR) produce high image quality with reduced artifacts.

“Image quality and dose management are two of our highest priorities,” said George Ebert, M.D., Ph.D., vice chair of imaging technology at Fletcher Allen Health Care. “By using iDose4 we can manage dose without sacrificing image quality. With O-MAR we achieve reduced artifacts caused by orthopedic implants. The iDose4 Premium Package is a smart offering of these two technologies.”

The iDose4 Premium Package was showcased at the International Society for Computed Tomography (ISCT) Annual International Symposium June 17-20 in San Francisco.

For more information: www.philips.us/iDose4PremiumPackage

Related Content

CT Offers Non-Invasive Alternative for Complex Coronary Disease Treatment Planning
News | CT Angiography (CTA) | October 16, 2018
A new study published in the European Heart Journal shows computed tomography (CT) can be a useful aid in heart team...

Images from computed tomography (CT) colonography show segmented abdominal aortic calcification measured with semiautomated CT tool on coronal image. Within region of interest over aorta selected by user, tool automatically segments and quantifies aortic calcification (shown in blue). 

Image Credit: O’Connor S D, Graffy P M, Zea R, et al. Does nonenhanced CT-based quantification of abdominal aortic calcification outperform the Framingham Risk Score in predicting cardiovascular event sin asymptomatic adults? Radiology doi: 10.1148/radiol.2018180562. Published online Oct. 2, 2018. © RSNA.

News | Computed Tomography (CT) | October 12, 2018
Computed tomography (CT)-based measures of calcification in the abdominal aorta are strong predictors of heart attacks...
Videos | Treatment Planning | October 08, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri
Videos | Treatment Planning | October 05, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri
Enterprise imaging has been a hot topic in radiology and healthcare information technology (IT) circles for the last several years as medical image acquisition has moved beyond the exclusive purview of radiology.
Feature | Enterprise Imaging | October 03, 2018 | By Jeff Zagoudis
Enterprise imaging has been a hot topic in radiology and healthcare information technology (IT) circles for the last...
Image Diagnostics Debuting Interventional Radiation Shield at RSNA 2018
News | Radiation Dose Management | October 03, 2018
Image Diagnostics has entered into a product development agreement with ECLS Inc. to design a new radiation shield...
Adherence to Annual Lung Cancer Screening Needs Improvement
News | Lung Cancer | October 03, 2018
A study of adherence to annual low-dose computed tomography (LDCT) screening within the Veteran Health Administration...
Brainlab and Magic Leap Partner in Digital Surgery
News | Advanced Visualization | September 28, 2018
September 28, 2018 — Brainlab announced a strategic development partnership with Florida-based Magic Leap, a develope
Bruker Introduces New High-Performance Preclinical PET/CT Si78 System
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...